Abstract:<table class="table article-section__table"><thead><tr><th class="bottom-bordered-cell center-aligned">Ultrasound</th><th class="bottom-bordered-cell center-aligned">Magnetic resonance imaging</th></tr><tr><th class="bottom-bordered-cell center-aligned">Agreement with laparoscopy (kappa value)</th><th class="bottom-bordered-cell center-aligned">Interobserver agreement (kappa value)</th><th class="bottom-bordered-cell center-aligned">Agreement with laparoscopy (kappa value)</th><th class="bottom-bordered-cell center-aligned">Interobserver agreement (kappa value)</th></tr><tr><th class="bottom-bordered-cell center-aligned">Trainee</th><th class="bottom-bordered-cell center-aligned">Expert</th><th class="bottom-bordered-cell center-aligned">Trainee vs Expert</th><th class="bottom-bordered-cell center-aligned">Trainee</th><th class="bottom-bordered-cell center-aligned">Expert</th><th class="bottom-bordered-cell center-aligned">Trainee vs Expert</th></tr></thead><tbody><tr><td class="right-bordered-cell center-aligned">Pelvis DE overall</td><td class="center-aligned">1st set</td><td class="center-aligned">0.39</td><td class="center-aligned">0.58</td><td class="center-aligned">0.58</td><td class="center-aligned">0.48</td><td class="center-aligned">0.71</td><td class="center-aligned">0.78</td></tr><tr><td class="center-aligned">2nd set</td><td class="center-aligned">0.54</td><td class="center-aligned">0.83</td><td class="center-aligned">0.71</td><td class="center-aligned">0.59</td><td class="center-aligned">0.79</td><td class="center-aligned">0.63</td></tr><tr><td class="center-aligned">3rd set</td><td class="center-aligned">0.48</td><td class="center-aligned">0.70</td><td class="center-aligned">0.74</td><td class="center-aligned">0.47</td><td class="center-aligned">0.75</td><td class="center-aligned">0.59</td></tr><tr><td class="right-bordered-cell left-aligned">Frozen pelvis</td><td class="center-aligned">1st set</td><td class="center-aligned">0.35</td><td class="center-aligned">0.51</td><td class="center-aligned">0.80</td><td class="center-aligned"> 0.04<a class="noteLink scrollableLink" href="#uog20561-note-0016_1">*</a><span class="footNotePopup"><span>All results were statistically significant, except values with * (p > .05)<br/></span></span></td><td class="center-aligned"> 0.15<a class="noteLink scrollableLink" href="#uog20561-note-0016_2">*</a><span class="footNotePopup"><span>All results were statistically significant, except values with * (p > .05)<br/></span></span></td><td class="center-aligned">0.72</td></tr><tr><td class="center-aligned">2nd set</td><td class="center-aligned">0.71</td><td class="center-aligned">0.77</td><td class="center-aligned">0.94</td><td class="center-aligned"> 0.03<a class="noteLink scrollableLink" href="#uog20561-note-0016_3">*</a><span class="footNotePopup"><span>All results were statistically significant, except values with * (p > .05)<br/></span></span></td><td class="center-aligned"> 0.29<a class="noteLink scrollableLink" href="#uog20561-note-0016_4">*</a><span class="footNotePopup"><span>All results were statistically significant, except values with * (p > .05)<br/></span></span></td><td class="center-aligned">0.61</td></tr><tr><td class="center-aligned">3rd set</td><td class="center-aligned">0.80</td><td class="center-aligned">0.74</td><td class="center-aligned">0.93</td><td class="center-aligned">0.27</td><td class="center-aligned">0.35</td><td class="center-aligned">0.84</td></tr></tbody></table><ul><li>All results were statistically significant, except values with * (p > .05)</li></ul>

OC21.03: Diagnostic accuracy of direct and indirect signs of adenomyosis and interrater reliability: a prospective multicentre study

OC21.04: Does hormone use influence the diagnostic performance of sonographic signs of adenomyosis: a prospective study

Innovative Ultrasound Criteria for the Diagnosis of Adenomyosis and Correlation with Symptoms: A Retrospective Re-Evaluation

OP17.06: Diagnosing adenomyosis using transvaginal contrast‐enhanced ultrasound: a pilot study

EP24.12: Prevalence of adenomyosis and endometriosis on ultrasound among symptomatic patients stratified by referring physician

OC20.07: Early learning curve in the assessment of deep infiltrating pelvic endometriosis when using ultrasound and magnetic resonance imaging

OP06.04: Discrimination of benign and malignant adnexal masses in daily clinical routine: external validation of ADNEX and RMI in Denmark – preliminary results

OP03.05: Detection of Vulvar International Tumor Analysis criteria among sonographers in lymph node evaluation: interrater reliability study

EP25.17: Ultrasound diagnosis of adenomyosis with histopathological correlation in women undergoing pre‐IVF ICSI treatment

EP23.19: Diagnostic accuracy of ultrasound scoring systems in differentiating benign versus malignant adnexal masses

Accuracy of findings in the diagnosis of uterine adenomyosis on ultrasound

Grading Sonographic Severity of Adenomyosis

OC21.02: *Endometrial assessment on ultrasound: why transvaginal scan alone is not good enough?

Indirect and atypical imaging signals of endometriosis: A wide range of manifestations

EP23.14: Diagnostic accuracy of adnexal malignancy assessment models ADNEX and simple rules when applied by individuals with no prior clinical experience

OC05.02: External validation of ultrasound‐based prediction models for discrimination between benign and malignant adnexal masses in Italy: IOTA phase 6 study

EP22.04: The accuracy of ultrasound in diagnosing adhesions around omental metastatic lesions of ovarian cancer

OC01.04: *AI‐driven ultrasound detection of ovarian cancer that generalises: an international multicentre validation study

Learning curve in the detection of ovarian and deep endometriosis by using Magnetic Resonance: comparison with surgical results

Prevalence of adenomyosis features in women scheduled for assisted reproductive treatment, using the Morphological Uterus Sonographic Assessment group definitions

Prevalence of endometriosis and adenomyosis at transvaginal ultrasound examination in symptomatic women